Kevin Hsueh

Medicine & Life Sciences

1. Anti-Bacterial Agents 100%
2. Candida 85%
3. Antimicrobial Stewardship 81%
4. Candidemia 77%
5. Infections 59%
6. Cohort Studies 59%
7. tedizolid 49%
8. Inappropriate Prescribing 42%
9. Outpatients 42%
10. Interrupted Time Series Analysis 38%
11. Dentists 38%
12. Cefepime 37%
13. Neutropenia 37%
14. Mortality 37%
15. Centers for Medicare and Medicaid Services (U.S.) 35%
16. Drug Evaluation 34%
17. Prescriptions 33%
18. Patient Safety 33%
19. Sepsis 30%
20. Endocarditis 29%
21. Cross Infection 28%
22. Interleukins 26%
23. Bacterial Infections 26%
24. Interleukin-4 25%
25. Upper Extremity 25%
26. Therapeutics 25%
27. Confidence Intervals 24%
28. Length of Stay 24%
29. Communicable Diseases 23%
30. Longitudinal Studies 23%
31. Pharmaceutical Preparations 23%
32. Emergencies 21%
33. Tooth 21%
34. Hand 21%
35. Pharmacokinetics 21%
36. Referral and Consultation 20%
37. Surgeons 19%
38. Formularies 18%
39. Retrospective Studies 18%
40. Tazobactam Drug Combination Piperacillin 18%
41. Comorbidity 17%
42. Meropenem 17%
43. Delivery of Health Care 17%
44. Linezolid 15%
45. Skin 15%
46. Amoxicillin 14%
47. Growth 14%
48. Hospital Mortality 13%
49. L-Amino Acid Oxidase 12%
50. Genes 11%